Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.17 - $0.26 $1,216 - $1,861
-7,158 Reduced 93.94%
462 $0
Q2 2022

Aug 10, 2022

SELL
$0.2 - $0.61 $1,361 - $4,152
-6,808 Reduced 47.19%
7,620 $2,000
Q1 2022

May 16, 2022

SELL
$0.48 - $0.74 $48,883 - $75,362
-101,841 Reduced 87.59%
14,428 $9,000
Q4 2021

Feb 14, 2022

BUY
$0.7 - $1.94 $71,959 - $199,430
102,799 Added 763.17%
116,269 $81,000
Q3 2021

Nov 15, 2021

BUY
$1.82 - $5.71 $5,247 - $16,461
2,883 Added 27.23%
13,470 $25,000
Q2 2021

Aug 13, 2021

BUY
$5.22 - $7.33 $49,015 - $68,828
9,390 Added 784.46%
10,587 $61,000
Q1 2021

May 12, 2021

SELL
$4.0 - $10.28 $44,028 - $113,151
-11,007 Reduced 90.19%
1,197 $8,000
Q4 2020

Feb 11, 2021

BUY
$2.43 - $4.68 $29,655 - $57,114
12,204 New
12,204 $45,000

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.